Read More Apparatus Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy! Nov 17, 2024
Read More Medical Significant Improvement In Survival For Pancreatic Cancer Patients! A first-Line NALIRIFOX Regimen To Look Forward To! Nov 23, 2024
Read More Apparatus Clinical Approval For Colombotide Skb264 (Mk-2870) In Combination With Oxitinib Dec 04, 2024
Read More Medical Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma Nov 26, 2024
